m Interim Analysis of the Myeloproliferative Disorders Research Consortium (MPD-RC) 112 Global Phase III Trial of Front Line Pegylated Interferon Alpha-2a Vs. Hydroxyurea in High Risk Polycythemia Vera and Essential Thrombocythemia

著录项

• 来源
  《Blood: The Journal of the American Society of Hematology》 |2016年第22期|共7页
• 作者

  Mascarenhas John O.; Prchal Josef T.; Rambaldi Alessandro; Mesa Ruben A.; Berenzon Dmitriy; Yacoub Abdulraheem; Harrison Claire N.; McMullin Mary Frances; Vannucchi Alessandro M.; Ewing Joanne C.; OConnell Casey L.; Kiladjian Jean-Jacques; Mead Adam; Winton Elliott F.; Leibowitz David S.; De Stefano Valerio; Arcasoy Murat O.; Kessler Craig M.; Catchatorian Rosalind; Rondelli Damiano; Silver Richard T.; Ritchie Ellen K.; Nagler Arnon; Kremyanskaya Marina; Schlenk Richard F.; Weinberg Rona Singer; Salama Mohamed E.; Tognoni Gianni; Prosperini Giuseppe; Di Lelio Alessandra; Serone Eliseo; Marfisi Lorenzo; Kleczko Jill; Kosiorek Heidi E.; Barbui Tiziano; Dueck Amylou C.; Hoffman Ronald;

  展开▼
• 作者单位

  展开▼
• 收录信息
• 原文格式 PDF
• 正文语种 eng
• 中图分类
• 关键词